Biovas
Latest round
- Series A
Last raised
- Nov 2015
Total raised
- Undisclosed
Investors
- 2
About Biovas
Established in 2013 and based in Wuhan, China, Biovas is a medical company that specializes in the production, development and sales of medical devices, providing minimally invasive circulatory intervention devices. The company has a production and research base covering 3,600 square meters. Biovas has received ISO 13485 quality system certification and NMPA Class III interventional medical device GMP approval. It has been recognized as a pilot unit for intellectual property rights by the Ministry of Industry and Information Technology, designated as a National High-Tech Enterprise, and awarded titles such as Specialized, Fined, Peculiar and Innovative Small and Medium Enterprise, and Gazelle Enterprise. The company has also been part of the Wuhan East Lake 3551 Optics Valley Talent Program. The company focuses on the development of medical devices for cardiovascular intervention, offering a comprehensive product line that includes coronary, peripheral, ENT (ear, nose, and throat), and respiratory interventional fields. The company's core technologies involve the processing of medical-use materials, high polymer materials, biodegradable materials, and drug-controlled release technologies. Biovas collaborates with several European and American medical device manufacturers and R&D institutions and has partnerships with over 50 authoritative clinical research centers across China for conducting clinical trials. The company holds 70 patents and has 19 product registration certificates, with more than 20 products in the process of type inspection or registration application. The company generates revenue by selling a range of cardiovascular interventional devices, providing high-quality medical products and technical support services to the healthcare sector.
Who invested in Biovas
2 investors across 2 rounds
See all investors in Biovas
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biovas
Who invested in Biovas?
Biovas has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biovas raised?
Biovas has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biovas last raise money?
Biovas's most recent round on record is a Series A, in Nov 2015.
What does Biovas do?
Established in 2013 and based in Wuhan, China, Biovas is a medical company that specializes in the production, development and sales of medical devices, providing minimally invasive circulatory intervention devices.
Where is Biovas headquartered?
Biovas is headquartered in Wuhan, China.
Which VCs invest in companies like Biovas?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Biovas's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Biovas? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.